Toward patient-centered outcomes for cognitive evaluations: the perspective of those affected by Parkinson's disease

被引:5
|
作者
Benge, Jared F. [1 ,2 ,3 ]
Heemsbergen, Teresa [4 ]
Nelson, Ronald A. [4 ]
Konesheck, David O. [4 ]
Konesheck, Bonny [4 ]
Aaron, Charles S. [5 ]
机构
[1] Baylor Scott & White Hlth, Div Neuropsychol, Dept Neurol, Temple, TX 77845 USA
[2] Baylor Scott & White Hlth, Plummer Movement Disorders Ctr, Temple, TX 77845 USA
[3] Texas A&M Hlth Sci Ctr, Dept Internal Med, Temple, TX 76508 USA
[4] Parkinsons Advocates Res PAIR, Parkinsons Fdn, New York, NY USA
[5] Parkinsons Support Grp, Georgetown Area, Georgetown, TX USA
关键词
Patient-centered outcomes research; neuropsychological evaluations; Parkinson's disease; mild cognitive impairment; cognitive evaluation; DIAGNOSTIC-CRITERIA; IMPAIRMENT; EXPERIENCE; PREDICTORS; SCALE; MOCA;
D O I
10.1080/13854046.2017.1414884
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: Patient-centered outcomes research is predicated on the idea that the opinions, attitudes, and preferences of patients should help inform study design and interpretation. To date, little is known about what defines patient-centered outcomes from cognitive evaluations. The current evaluation sought to explore this issue in persons with Parkinson's disease (PwPD) and their care partners (CP). Method: Focus groups of 22 PwPD/CP dyads were conducted to identify potential consumer oriented endpoints from cognitive evaluations. These endpoints were utilized to create a Patient-Centered Cognitive Assessment Outcomes Scale, which was administered to a different group of 50 PwPD/CP dyads who rated the importance of each outcome and identified their top three priority outcomes. Results: Three themes emerged from the focus groups: improved knowledge, advice, and planning. Both PwPD and CP rated items in all three domains as being very important outcomes. Priorities for outcomes in both groups favored treatment planning information slightly above knowledge based outcomes. Conclusions: The PwPD and CP identified improved knowledge, advice for daily activities, and knowledge they could use to plan for future eventualities as very important. This information can be used as a framework for future studies aimed at demonstrating patient-centered outcomes from neuropsychological evaluations. Implications for future research are discussed.
引用
收藏
页码:1303 / 1318
页数:16
相关论文
共 50 条
  • [21] Genomic determinants of motor and cognitive outcomes in Parkinson's disease
    Chung, Sun Ju
    Armasu, Sebastian M.
    Biernacka, Joanna M.
    Anderson, Kari J.
    Lesnick, Timothy G.
    Rider, David N.
    Cunningham, Julie M.
    Ahlskog, J. Eric
    Frigerio, Roberta
    Maraganore, Demetrius M.
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (07) : 881 - 886
  • [22] Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson's Disease
    Ricciardi, Carlo
    Amboni, Marianna
    De Santis, Chiara
    Ricciardelli, Gianluca
    Improta, Giovanni
    D'Addio, Giovanni
    Cuoco, Sofia
    Picillo, Marina
    Barone, Paolo
    Cesarelli, Mario
    2020 IEEE INTERNATIONAL SYMPOSIUM ON MEDICAL MEASUREMENTS AND APPLICATIONS (MEMEA), 2020,
  • [23] Computerized cognitive testing in patients with Parkinson's disease: an Indian perspective
    Mandal, Moulika
    Srivastava, Kashish
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2023, 13 (04) : 235 - 243
  • [24] A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologies
    Espay, Alberto J.
    Hausdorff, Jeffrey M.
    Sanchez-Ferro, Alvaro
    Klucken, Jochen
    Merola, Aristide
    Bonato, Paolo
    Paul, Serene S.
    Horak, Fay B.
    Vizcarra, Joaquin A.
    Mestre, Tiago A.
    Reilmann, Ralf
    Nieuwboer, Alice
    Dorsey, E. Ray
    Rochester, Lynn
    Bloem, Bastiaan R.
    Maetzler, Walter
    MOVEMENT DISORDERS, 2019, 34 (05) : 657 - 663
  • [25] Can volumetric magnetic resonance imaging evaluations be helpful in the follow-up of cognitive functions in cognitively normal Parkinson's disease patients?
    Uysal, Hasan Armagan
    Hunerli, Duygu
    Cakmur, Raif
    Donmez Colakoglu, Beril
    Ada, Emel
    Yener, Gorsev
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2024, 54 (04) : 688 - 699
  • [26] Knowledge and attitudes towards genetic testing in those affected with Parkinson's disease
    Scuffham T.M.
    McInerny-Leo A.
    Ng S.-K.
    Mellick G.
    Journal of Community Genetics, 2014, 5 (2) : 167 - 177
  • [27] Driving and Parkinson's Disease: A Survey of the Patient's Perspective
    Brock, Peter
    Oates, Lloyd L.
    Gray, William K.
    Henderson, Emily J.
    Mann, Helen
    Haunton, Victoria J.
    Skelly, Rob
    Hand, Annette
    Davies, Matthew L.
    Walker, Richard W.
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (01) : 465 - 471
  • [28] Stem Cell-based and Advanced Therapeutic Modalities for Parkinson's Disease: A Risk-effectiveness Patient-centered Analysis
    Salahi, Sarvenaz
    Mousavi, Maryam Alsadat
    Azizi, Gholamreza
    Hossein-Khannazer, Nikoo
    Vosough, Massoud
    CURRENT NEUROPHARMACOLOGY, 2022, 20 (12) : 2320 - 2345
  • [29] Latent Cognitive Phenotypes in De Novo Parkinson's Disease: A Person-Centered Approach
    LaBelle, Denise R.
    Walsh, Ryan R.
    Banks, Sarah J.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2017, 23 (07) : 551 - 563
  • [30] Perspective on the Road toward Gene Therapy for Parkinson's Disease
    Blits, Bas
    Petry, Harald
    FRONTIERS IN NEUROANATOMY, 2017, 10